121 related articles for article (PubMed ID: 11445810)
1. A mutation in Bruton's tyrosine kinase as a cause of selective anti-polysaccharide antibody deficiency.
Wood PM; Mayne A; Joyce H; Smith CI; Granoff DM; Kumararatne DS
J Pediatr; 2001 Jul; 139(1):148-51. PubMed ID: 11445810
[TBL] [Abstract][Full Text] [Related]
2. Mutation pattern in the Bruton's tyrosine kinase gene in 26 unrelated patients with X-linked agammaglobulinemia.
Vorechovský I; Luo L; Hertz JM; Frøland SS; Klemola T; Fiorini M; Quinti I; Paganelli R; Ozsahin H; Hammarström L; Webster AD; Smith CI
Hum Mutat; 1997; 9(5):418-25. PubMed ID: 9143921
[TBL] [Abstract][Full Text] [Related]
3. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.
Thomas JD; Sideras P; Smith CI; Vorechovský I; Chapman V; Paul WE
Science; 1993 Jul; 261(5119):355-8. PubMed ID: 8332900
[TBL] [Abstract][Full Text] [Related]
4. Brief report: a point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia.
Saffran DC; Parolini O; Fitch-Hilgenberg ME; Rawlings DJ; Afar DE; Witte ON; Conley ME
N Engl J Med; 1994 May; 330(21):1488-91. PubMed ID: 8164701
[No Abstract] [Full Text] [Related]
5. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
Gaspar HB; Lester T; Levinsky RJ; Kinnon C
Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Bruton's tyrosine kinase mutations in Mexican patients with X-linked agammaglobulinemia.
Lopez-Herrera G; Berron-Ruiz L; Mogica-Martinez D; Espinosa-Rosales F; Santos-Argumedo L
Mol Immunol; 2008 Feb; 45(4):1094-8. PubMed ID: 17765309
[TBL] [Abstract][Full Text] [Related]
7. X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease.
Mattsson PT; Vihinen M; Smith CI
Bioessays; 1996 Oct; 18(10):825-34. PubMed ID: 8885720
[TBL] [Abstract][Full Text] [Related]
8. Characterization of germline mutations of the gene encoding Bruton's tyrosine kinase in families with X-linked agammaglobulinemia.
Hagemann TL; Rosen FS; Kwan SP
Hum Mutat; 1995; 5(4):296-302. PubMed ID: 7627183
[TBL] [Abstract][Full Text] [Related]
9. A case of X-linked agammaglobulinemia diagnosed in adulthood.
Stewart DM; Tian L; Nelson DL
Clin Immunol; 2001 Apr; 99(1):94-9. PubMed ID: 11286545
[TBL] [Abstract][Full Text] [Related]
10. xid affects events leading to B cell cycle entry.
Brorson K; Brunswick M; Ezhevsky S; Wei DG; Berg R; Scott D; Stein KE
J Immunol; 1997 Jul; 159(1):135-43. PubMed ID: 9200448
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of Bruton's tyrosine kinase gene in Spain.
Rodríguez MC; Granados EL; Cerdán AF; Casariego GF
Hum Mutat; 2001; 18(1):84. PubMed ID: 11438999
[TBL] [Abstract][Full Text] [Related]
12. Identification of nine novel mutations in the Bruton's tyrosine kinase gene in X-linked agammaglobulinaemia patients.
Orlandi P; Ritis K; Moschese V; Angelini F; Arvanitidis K; Speletas M; Sideras P; Plebani A; Rossi P
Hum Mutat; 2000 Jan; 15(1):117. PubMed ID: 10612838
[TBL] [Abstract][Full Text] [Related]
13. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis.
Kanegane H; Futatani T; Wang Y; Nomura K; Shinozaki K; Matsukura H; Kubota T; Tsukada S; Miyawaki T
J Allergy Clin Immunol; 2001 Dec; 108(6):1012-20. PubMed ID: 11742281
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation leading to a deletion in the SH3 domain of Bruton's tyrosine kinase.
Mesci L; Ozdag H; Turul T; Ersoy F; Tezcan I; Sanal O
Turk J Pediatr; 2006; 48(4):362-4. PubMed ID: 17290574
[TBL] [Abstract][Full Text] [Related]
15. Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia.
Schuster V; Seidenspinner S; Kreth HW
Am J Med Genet; 1996 May; 63(1):318-22. PubMed ID: 8723128
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis of the gene encoding Bruton's tyrosine kinase in a family with a sporadic case of X-linked agammaglobulinemia reveals three female carriers.
Hagemann TL; Assa'ad AH; Kwan SP
Am J Med Genet; 1995 Nov; 59(2):188-92. PubMed ID: 8588584
[TBL] [Abstract][Full Text] [Related]
17. Identification of mutations of Bruton's tyrosine kinase gene (BTK) in Brazilian patients with X-linked agammaglobulinemia.
Tani SM; Wang Y; Kanegane H; Futatani T; Pinto J; Vilela MM; Miyawaki T
Hum Mutat; 2002 Sep; 20(3):235-6. PubMed ID: 12204007
[TBL] [Abstract][Full Text] [Related]
18. Bruton's tyrosine kinase mutations in 8 Chinese families with X-linked agammaglobulinemia.
Yip KL; Chan SY; Ip WK; Lau YL
Hum Mutat; 2000 Apr; 15(4):385. PubMed ID: 10737994
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the Btk gene in 12 unrelated families with X-linked agammaglobulinemia in Japan.
Kobayashi S; Iwata T; Saito M; Iwasaki R; Matsumoto H; Naritaka S; Kono Y; Hayashi Y
Hum Genet; 1996 Apr; 97(4):424-30. PubMed ID: 8834236
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of Bruton's tyrosine kinase domain suggests a novel pathway for activation and provides insights into the molecular basis of X-linked agammaglobulinemia.
Mao C; Zhou M; Uckun FM
J Biol Chem; 2001 Nov; 276(44):41435-43. PubMed ID: 11527964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
